d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
htm target=_blank>business start-up loans. Lenders offering business start-up loans tend to adopt a f
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
exible approach while deciding upon the terms and conditions of the loan. This is because the lenders are
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
aware that you are just starting up a business and the business will take time to pick up pace.
There a
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
e two types of business start-up loans, secured and unsecured. If you have a property and you are ready t
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
o pledge it to get loan, then secured business start-up loans is the suitable choice. In this case, you g
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
t the benefits of getting approval for a larger loan amount, paying a lower interest rate and settling fo
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
flexible repayment options. This proves to be a great boon, especially when you are starting up a busine
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
ss. However, if you don’t own a property or do not wish to risk your property, then you should opt for un
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ecured business start-up loans. This loan option is suitable if you plan to start up a small business and
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
require a small loan amount for that. With unsecured loan option, the loan is approved fast as no proper
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
y evaluation is required. This enables you to receive money on time and start up the business as early as
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
possible. Moreover, a bad credit record of an entrepreneur does not hinder him/her from taking unsecured
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
business start-up loans. The borrower needs to convince the lender about his/her repaying capability thro
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ugh bank statements, annual income proof, etc.
So, do not let your business sketches lie on the paper. G
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
ve them life with business start-up loans and see your business skyrocket to the zenith of success
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
